BioNTech SE is 18.7x more valuable than Hemab Therapeutics Holdings, Inc. by market capitalization ($21.79 B vs $1.17 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | COAG | BNTX |
|---|---|---|
| Market cap | $1.17 B | $21.79 B |
| US-listed rank | #2524 | #587 |
| SEC filings | 38 | 548 |
BioNTech SE is 18.7x more valuable than Hemab Therapeutics Holdings, Inc. by market capitalization ($21.79 B vs $1.17 B).
Full pages: Hemab Therapeutics Holdings, Inc. and BioNTech SE, or browse the full rankings.